Primary hyperparathyroidism
ICD-10 E21.0 · ICD-11 5A51.0

Treatment of Primary Hyperparathyroidism with Single-Gland Disease and Concordant Localisation Imaging

Clinical Scenario

This protocol covers primary hyperparathyroidism (PHPT) in patients with single-gland disease — specifically a single adenoma — where parathyroid localisation imaging is concordant. Multi-gland disease is absent and no genetic or familial risk factors for multi-gland involvement are present.

The majority of PHPT patients have single-gland disease. A focused surgical approach is appropriate after discussion with the patient regarding the possibility of persistent disease.

Surgical Approach

In this setting, a minimally invasive, targeted surgical approach to the parathyroid is the indicated intervention. The complete operative protocol — including intraoperative management of the parathyroid tissue — is specified in the full regimen.

Clinical Goal

The primary outcome target is eucalcaemia — normal serum calcium — confirmed at 6 months after surgery, which defines surgical cure.

References

DOI: 10.1111/cen.14650

Minimally invasive parathyroidectomy is appropriate in most patients with concordant imaging.

The majority of PHPT patients have single gland disease and a focussed approach is appropriate following discussion with the patient regarding the possibility of persistent disease.

When a normal parathyroid gland is de-vascularised in parathyroidectomy for sporadic disease, it should be auto-transplanted.

Serum calcium should be measured 6 months after parathyroidectomy.

Cure is defined as eucalcaemia 6 months after parathyroidectomy.

Eucalcaemia at 6 months is consistent with surgical cure; parathyroid hormone levels do not need to be re-checked in the absence of other clinical indications.

View source ↗